Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol - TCTMD

A new method of distinguishing Lp(a) in blood samples has implications for LDL tests and patient care, researchers say.

A new report helps shed some light on the effects of the novel antisense oligonucleotide pelacarsen (Novartis) on various cholesterol targets, including LDL cholesterol and lipoprotein(a). Pelacarse… [+7249 chars]

full article...